Literature DB >> 9331576

Vocational perspectives and neuromuscular disorders.

F Andries1, C W Wevers, A R Wintzen, H F Busch, C J Höweler, A E de Jager, G W Padberg, M de Visser, J H Wokke.   

Abstract

The present study analyses the actual occupational situation, vocational handicaps and past labour career of a group of about 1000 Dutch patients suffering from a neuromuscular disorder (NMD). On the basis of the likelihood of a substantial employment history and sufficient numbers of patients, four types of NMD were selected: dystrophia myotonica (DM), hereditary motor and sensory neuropathy, (HMSN), spinal muscular atrophy (SMA) and myasthenia gravis (MG). Results show that a labour career is in reach of most NMD patients, even for those with severe limitations. It is concluded that physical limitations seem not to be decisive in that respect. The loss of the quality of communication, the loss of mental abilities and the effect of the diseases on the facial expression, as with some DM patients, are also important for chances on the labour market. Though the labour participation of NMD patients tends to decrease after the age of 34, the availability of work adaptations makes it possible to prolong the labour career. Analysis of the actual work situation of NMD patients shows that both disorder-related limitations and work characteristics play an important role in the amount of physical work problems encountered. It is argued that physical labour has to be regarded as generally unsuitable for NMD patients. This has implications for the sort and level of education to be attained by NMD patients. Career counselling as a focus point for the choice of an educational programme may improve labour market opportunities as well as quality of employment of NMD patients. Allowing for and accepting the possible effects of the disorder in the work situation are considered to be important in respect to labour participation and work satisfaction of workers with NMD. Reducing time pressure demands and increasing the freedom to organize one's work, are measures to be given especial consideration.

Entities:  

Mesh:

Year:  1997        PMID: 9331576     DOI: 10.1097/00004356-199709000-00003

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  7 in total

1.  Employment perspectives of patients with ankylosing spondylitis.

Authors:  A M J Chorus; A Boonen; H S Miedema; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

2.  Employment and disability for work in patients with COPD: a cross-sectional study among Dutch patients.

Authors:  A M Kremer; T M Pal; A R J van Keimpema
Journal:  Int Arch Occup Environ Health       Date:  2006-04-08       Impact factor: 3.015

3.  Work factors and behavioural coping in relation to withdrawal from the labour force in patients with rheumatoid arthritis.

Authors:  A M Chorus; H S Miedema; C W Wevers; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

4.  A multidisciplinary job retention vocational rehabilitation programme for patients with chronic rheumatic diseases: patients' and occupational physicians' satisfaction.

Authors:  P D M de Buck; J Breedveld; F J van der Giesen; T P M Vliet Vlieland
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

5.  How persons with a neuromuscular disease perceive employment participation: a qualitative study.

Authors:  Marie-Antoinette H Minis; Ton Satink; Astrid Kinébanian; Josephine A Engels; Yvonne F Heerkens; Baziel G M van Engelen; Maria W G Nijhuis-van der Sanden
Journal:  J Occup Rehabil       Date:  2014-03

6.  Dental Videographic Analysis using Digital Age Media.

Authors:  Anirudh Agarwal; Karan Seth; Siddharaj Parmar; Rahul Jhawar
Journal:  Int J Clin Pediatr Dent       Date:  2016-12-05

7.  Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review.

Authors:  Hamish W Y Wan; Kate A Carey; Arlene D'Silva; Steve Vucic; Matthew C Kiernan; Nadine A Kasparian; Michelle A Farrar
Journal:  Orphanet J Rare Dis       Date:  2020-03-12       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.